Tivozanib for the treatment of renal cell carcinoma-Reference-Cited by-同舟云学术

Tivozanib for the treatment of renal cell carcinoma

Published:2018-05-31 Issue:9 Volume:19 Page:1021-1025
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Santoni Matteo¹,Massari Francesco²,Piva Francesco³,Carrozza Francesco⁴,Di Nunno Vincenzo²,Cimadamore Alessia⁵,Martignetti Angelo⁶,Montironi Rodolfo⁵,Battelli Nicola¹

Affiliation:

1. Oncology Unit, Macerata Hospital, Macerata, Italy

2. Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy

3. Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy

4. Oncology Unit, City Hospital, Faenza, Italy

5. Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy

6. Dipartimento oncologico uslsudest toscana- area senese, Poggibonsi, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1480722

Reference32 articles.

1. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2018/; [accessed 18th February 2018].

2. Roskoski R Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression, Crit Rev Oncol Hematol. 2007;62:179–213.

3. The VHL Tumor Suppressor: Master Regulator of HIF

4. Expression of vascular endothelial growth factor protein in human renal cell carcinoma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DRN-CDR: A cancer drug response prediction model using multi-omics and drug features;Computational Biology and Chemistry;2024-10

2. FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect;Heliyon;2024-01

3. HPLC methods for studying pharmacokinetics of tivozanib and in vitro metabolic interaction with dexamethasone in rat;Journal of Pharmaceutical and Biomedical Analysis;2023-08

4. Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies;Journal of Biomolecular Structure and Dynamics;2023-04-08

5. Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis;BMC Medical Genomics;2021-10-07